106 Results for "

HUVEC

" in MedChemExpress (MCE) Product Catalog:
Products (106)

106 Results for "HUVEC" in MCE Product Catalog:

Cat. No.: HY-120200
CAS No.: 1951466-83-3
Target:  

VEGFR

Research Areas:  

Cardiovascular Disease Cancer

YF-452 is a potent inhibitor of vascular endothelial growth factor receptor 2 (VEGFR2). YF-452 remarkably inhibits the migration, invasion and tube-like structure formation of human umbilical vein endothelial cells (HUVECs) with little toxicity. YF-452 inhibits VEGF-induced phosphorylation of VEGFR2 kinase and the downstream protein kinases including extracellular signal regulated kinase (ERK), focal adhesion kinase (FAK) and Src. YF-452 is a potential antiangiogenic agent candidate for cancer research .
loading...
    loading...
Cat. No.: HY-149921
Target:  

Src p38 MAPK

Research Areas:  

Cancer

Antiangiogenic agent 3 (compound 3) is a potent antiangiogenic agent. Antiangiogenic agent 3 is an inhibitor of human umbilical vein endothelial cells (HUVEC). Antiangiogenic agent 3 inhibits HUVEC migration and chemotactic motilities. Antiangiogenic agent 3 also decreases the gene expression of Src, cdc42, and MAPK .
loading...
    loading...
Cat. No.: HY-124918
CAS No.: 107585-69-3
Target:  

VEGFR

Research Areas:  

Cancer

Cremastranone is an antiangiogenic homoisoflavone. Cremastranone can inhibit HUVECs cell proliferation, with a GI50 value of 1.5 uM .
loading...
    loading...
Cat. No.: HY-147890
CAS No.: 2151067-32-0
Target:  

Apoptosis

Research Areas:  

Cancer

Angiogenesis inhibitor 2 (compound 72) is a potent angiogenesis inhibitor. Angiogenesis inhibitor 2 inhibits the proliferation of HUVEC and HCT-15 cells, with IC50 values of 1.93 and 0.21 μM. Angiogenesis inhibitor 2 induces the apoptosis of HUVEC and HCT-15 cells. Angiogenesis inhibitor 2 shows anticancer activity, and suppresses the invasion of cancer cells. Angiogenesis inhibitor 2 inhibits the angiogenesis in zebrafish embryos .
loading...
    loading...
Cat. No.: HY-147891
CAS No.: 2507759-39-7
Target:  

Apoptosis

Research Areas:  

Cancer

Angiogenesis inhibitor 3 (compound 8) is a potent angiogenesis inhibitor. Angiogenesis inhibitor 3 inhibits the proliferation of HUVEC and HCT-15 cells, with IC50 values of 1.00 and 0.71 μM. Angiogenesis inhibitor 3 induces the apoptosis of HUVEC and HCT-15 cells. Angiogenesis inhibitor 3 shows anticancer activity, and suppresses the invasion of cancer cells. Angiogenesis inhibitor 3 inhibits the angiogenesis in zebrafish embryos .
loading...
    loading...
Cat. No.: HY-N14190
CAS No.: 431935-18-1
Target:  

Others

Macrosphelide L is a cell adhesion inhibitor. Macrosphelide L inhibits the adhesion of HL-60 cells to HU-VEC cells with an IC50 of 5.6 μM .
loading...
    loading...
Cat. No.: HY-N14739
CAS No.: 1097679-78-1
Target:  

Ras

Dykellic acid is a RhoA inhibitor. Dykellic acid can inhibit the migration and motility of B16 cells and the tube formation of HUVECs. Dykellic acid is promising for research of cancers .
loading...
    loading...
Cat. No.: HY-155174
CAS No.: 2974488-31-6
Target:  

Akt

Research Areas:  

Cancer

Antiangiogenic agent 4 (Compound 3b) inhibits Akt phosphorylation in HFF and HUVEC cells. Antiangiogenic agent 4 can be used for cancer research .
loading...
    loading...
Cat. No.: HY-120544
CAS No.: 1256941-06-6
BAY-386, a chemical probe, is a PAR-1 antagonist that inhibits the expression of pro-inflammatory factors MCP-1 and CXCL1 in HUVEC .
loading...
    loading...
Cat. No.: HY-164551
CAS No.: 1423126-69-5
Target:  

VEGFR STAT ERK Apoptosis

Research Areas:  

Cancer

YLL545 is a type of vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor. YLL545 can inhibit VEGF-induced phosphorylation of VEGFR2 and the activation of downstream signaling factors (like phosphorylated STAT3 and phosphorylated ERK1/2) in human umbilical vein endothelial cells (HUVEC). YLL545 can suppress the proliferation, migration, invasion, and angiogenesis of HUVEC. YLL545 can induce apoptosis in breast cancer mice and inhibit tumor growth .
loading...
    loading...
Cat. No.: HY-P5877
CAS No.: 1072301-79-1
Target:  

PKC

Research Areas:  

Inflammation/Immunology

PKC(85-92),Myristoylated is a cell permeable myristic acid conjugated PKC peptide activator that enhances NO release in cultured human umbilical vein endothelial cells (HUVECs) .
loading...
    loading...
Cat. No.: HY-151996
CAS No.: 3033553-03-3
Target:  

Microtubule/Tubulin

Research Areas:  

Cardiovascular Disease

Tubulin inhibitor 31 is a potent tubulin inhibitor with an IC50 value of 4 μM. Tubulin inhibitor 31 shows anti-proliferative activity. Tubulin inhibitor 31 inhibits the HUVEC migration .
loading...
    loading...
Cat. No.: HY-N4020
CAS No.: 126176-79-2
Icariside E5 is a lignan glycoside isolated from the Capsicum annuum. Icariside E5 promotes the proliferation of HUVECs without cytotoxicity. Icariside E5 has antioxidant properties .
loading...
    loading...
Cat. No.: HY-112353
CAS No.: 949164-80-1
Target:  

Endogenous Metabolite

Research Areas:  

Others

NP603 is a potent inhibitor of FGF receptor 1, exhibiting remarkable activity against endothelial proliferation in HUVEC cells stimulated by rhFGF-2, with a minimum effective dose of 0.4 microM.
loading...
    loading...
Cat. No.: HY-P5888
CAS No.: 1072301-78-0
Synonyms: Myr‐PKCɛ-
Target:  

PKC

Research Areas:  

Inflammation/Immunology

PKCε inhibitor peptide,myristoylated (Myr-PKCε-) is a cell permeable myristic acid conjugated PKC peptide inhibitor that attenuates NO release in cultured human umbilical vein endothelial cells (HUVECs) .
loading...
    loading...
Cat. No.: HY-175820
Target:  

VEGFR ERK Apoptosis EGFR

Research Areas:  

Cancer

AGW-11 is a potent dual inhibitor of EGFR (IC50 = 556 nM) and VEGFR2 (IC50 = 289.7 nM). AGW-11 induces apoptosis and suppresses phosphorylation of EGFR, VEGFR2, and ERK1/2 in HUVECs. AGW-11 effectively inhibits cancer cell growth, reduces HUVEC proliferation, tube formation, and invasion, thereby blocking angiogenesis. AGW-11 significantly suppresses tumor growth and decreases lung metastasis in a 4T1 xenograft mouse model. AGW-11 can be used for the study of breast cancer .
loading...
    loading...
Cat. No.: HY-169520
CAS No.: 342785-98-2
Target:  

VEGFR

Research Areas:  

Cancer

VEGFR/PDGFR-IN-1 (Compound 1) is the inhibitor for VEGFR with an IC50 of 0.4 μM. VEGFR/PDGFR-IN-1 inhibits angiogenesis in HUVEC cell, exhibiting potential in tumor growth and metastasis inhibition .
loading...
    loading...
Cat. No.: HY-136829
CAS No.: 946417-21-6
Target:  

Apoptosis

Research Areas:  

Others

BPH-675 is a large bisphosphonate inhibitor with long hydrophobic side chains and a potent and selective geranylgeranyl diphosphate synthase (GGPPS) inhibitor with an IC50 of 0.71 μM. GGPPS inhibitor promotes HUVEC apoptosis .
loading...
    loading...
Cat. No.: HY-18333
CAS No.: 1018927-63-3
Target:  

VEGFR

Research Areas:  

Cancer

EG00229 is an inhibitor for VEGF-A and NRP1 interaction with an IC50 of 8 μM. EG00229 inhibits the migration of HUVECS and the phosphorylation of VEGFR2 in endothelial cells. EG00229 exhibits cytotoxicity in cancer cell A549 .
loading...
    loading...
Cat. No.: HY-161330
Target:  

Bacterial

Research Areas:  

Infection

Anti-MRSA agent 10 (Compound 2d) is a Cephalosporin (HY-144229) derivative and exhibits antibacterial activity. Anti-MRSA agent 10 is slightly drug resistane and exhibits low cytotoxicity in cells HUVEC and HBZY-1 .
loading...
    loading...